$MBRX Income Statement | Understand Stock

$MBRX

$8.75 -$0.52 (5.61%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Operating expenses:
Research and development
General and administrative
Depreciation and amortization
Total operating expenses
Loss from operations
Other income:
Gain from change in fair value of warrant liabilities
Loss on issuance of warrant liabilities
Transaction costs allocated to warrant liabilities
Loss on extinguishment of warrant liabilities
Other (expense) income, net
Interest income, net
Net loss
Net loss per common share - basic and diluted (in dollars per share)
Weighted average common shares outstanding, basic and diluted (in shares)

Other comprehensive loss:
Foreign currency translation
Comprehensive loss
Warrant deemed dividend
Net loss available to common stockholders
Net loss per common share - basic and diluted (in dollars per share)
Weighted average common shares outstanding, basic and diluted (in shares)

Comments